ArticleBMC microbiology2025
Isolation and characterization of a novel phage belonging to a new genus against Enterococcus faecium.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A comprehensive analysis of the kinetics of infection of lytic bacteriophages specific to the ESKAPE and critical pathogens.World journal of microbiology & biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Enterococcus faecium is a Gram-positive bacterium commonly found in the intestines of humans and animals. While certain strains exhibit probiotic properties, others have become significant pathogens due to their high level of antibiotic resistance. Bacteriophages, as natural bacterial predators, have emerged as promising alternatives for controlling bacterial infections, especially antibiotic-resistant strains. In this study, we isolated and characterized a novel bacteriophage, Enterococcus phage XWef1, which targets E. faecium, from waste materials of a feed additive production industry. The phage displayed optimal activity at pH levels between 6 and 8, with high stability at temperatures below 40 °C. It exhibited a narrow host range. Genomic analysis revealed 63 open reading frames (ORFs), including genes related to structural proteins, DNA replication, and host lysis. The comparative genomic analysis showed that XWef1 has less than 70% intergenomic similarities with its most similar phages. Thus, we propose that XWef1 is a novel Enterococcus phage belonging to a new genus. The discovery of XWef1 not only enriches our understanding of phage diversity but also offers new perspectives for phage research and development, with promising implications for microbial control and therapeutic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.